MBNL inhibition in DM1 tissues leads to a shift from adult to fetal splicing events for MBNL-targeted RNAs and results in tissue-specific disease manifestations, including muscle hyperexcitability (myotonia) and insulin resistance. The gene discussed is MBNL1; the disease is Myotonia.